Who We Are

OUR MARKET ACCESS CONSULTANCY TEAM

Our clients operate in dual environments - life science and business - and we shape our teams around the common challenges facing these segments. Valid Insight’s international team draw on decades of market access, medical and relevant commercial experience.

Janice Haigh

Chief Executive Office

From March 2017 until October 2021 Janice was Vice President and global lead for market access at Parexel Access consulting prior to which she was the European P&MA lead in Quintiles Advisory Services from 2012 until 2017.

Between 2006 to December 2011 Janice was Senior Director Pricing and Market Access for Astellas Pharma Europe where she was responsible for

the development and implementation of pricing and market access strategy for new and in-market products, working closely with brand teams and affiliates
price management, analysing the effect of price changes on other markets
designing, implementing and managing Astellass supply chain integrity program which ensured the matching of supply and demand of products in Europe.

Before joining Astellas in 2006, Janice worked in consultancy for 20 years, including 10 years at IMS Health/Cambridge Pharma Consultancy.

Responsible for leading projects involving pricing, parallel trade, health economics, evidence development/endpoint strategy and health policy. Clients have included European and global pharmaceutical companies but also trade associations and government bodies such as the European Commission.

James Wright
MSc

Senior Director Operations / COO

James Wright is Senior Director of Operations/ COO at Valid Insight and leads the global consulting teams. James has a wealth of experience in global operations, commercial strategy and business performance. His focus is in developing business relationships alongside team development and he has a central role in overseeing and implementing company strategy.

James has over 20 years’ experience in healthcare and consulting, starting with working in the UK NHS, then later in international pharmaceutical consultancy firms. He spent 13 years at Quintiles (IQVIA) in the commercial consulting group, prior to joining Valid Insight in 2017, quickly taking on roles in leadership and senior management. James has worked with most of the top 30 pharmaceutical companies and has extensive experience in market access optimisation, evaluation of strategic pricing and market access implications for new launches, and product/portfolio lifecycle optimisation.

James has been instrumental in building and managing the international multidisciplinary team along with diversified client solutions that have supported company growth.

James has an MSc in Health Economics and Pharmacoeconomics from Universitat Pompeu Fabra and joined Valid Insight after 13 years at IQVIA.

Frank Cousins
BSc (Hons.)

Senior Director Commercial Strategy/ CCO

Frank Cousins is Senior Director and CCO at Valid Insight with nearly 25 years of experience as a consultant to the pharmaceutical industry. Frank leads our commercial strategy and business development, and as a seasoned professional, works in close partnership with our clients to help define and solve their challenges as they seek to optimal access and commercial success.

Before joining Valid Insight, Frank’s career started with over 12 years in healthcare and medical communications, both educational and commercial, followed by 10 years with Quintiles Consulting/IQVIA working in a range of senior commercial consulting positions. His experience is end-to-end from evidence generation and clinical trial optimisation projects through to launch and eventual loss of exclusivity. He has worked across multiple therapy areas and with the majority of top 25 global biopharmaceutical and biotechnology companies.

Frank has always been a strong advocate of collaboration, working closely with client teams and harnessing their own experience which has delivered exceptional results for our customers and ensuring high levels of repeat engagements. Having previously gained extensive consulting experience through leading complex multifaceted programs, he now focusses on supporting clients identify and resolve key strategic business questions and helping our teams deliver the highest standards in solution design by providing insight to ensure practical and pragmatic recommendations. This leadership approach, has delivered real commercial success for both our clients and our business, but importantly, also ensures that our teams are always learning and developing new approaches to the market access challenges our clients face.

During his career, Frank has led a diverse mix of management, commercial and clinical consulting projects that have included organisational design, alliance and partnership evaluation, market evaluation, payer and pricing strategies and eHealth initiatives. Frank’s interests include the integration of regulatory strategy, evidence generation (including clinical studies, real world evidence, and patient centric and PRO data), and market access for optimal launch and commercial planning. He has developed a high level of expertise in early regulatory approval and its implications for HTA, market access, and pricing and reimbursement. He also focuses on the nuances of successful differentiation in tendering and contracting, supporting companies maintain price and position during the life-cycle.

Frank has a BSc (Hons) in Biology from St Andrews University and joined Valid insight in 2018 after 4 years at Parexel and 10 years with IQVIA.

Raf De Wilde

PhD

Senior Executive Advisor

Raf De Wilde is Senior Executive Advisor at Valid Insight. He is a global expert in life science market access, having over 40 years’ experience in the pharmaceutical industry and over 30 years in global market access.

Raf became the head of International Marketing Services within Janssen Pharmaceutica (a Johnson & Johnson (J&J) company) in 1991, introducing Health Economics at J&J that year. Raf was Chairman of EPhMRA Primary Research and Methods Committee (1993-1995). He became VP of EPhMRA in 1994 and 1997 and President in 1995 and 1998.

In 1997, he joined Peter Lauper’s team that pioneered the ‘biosimilars’ concept and the first patient access schemes. Raf led a specialist oncology, real-world evidence and virology group between 2002 and 2004, where he created a centre of excellence for oncology pricing and specialised in biologics while leading the HEOR function at CENTOCOR. Raf was VP of Market Access at J&J leading teams working on oncology, cardiovascular and biotech products from 2004 to 2010.

Raf joined United Biosource Corporation (UBC) as Associate VP in early 2011 and stayed with Evidera until 2015, prior to joining Valid Insight in 2016. In his consulting career he has led nearly 200 global market access projects, including value strategies, price finding research, patient access schemes, negotiation tactics, tendering and contracting, WHO classification and naming strategies. He has moderated over 150 training workshops in Asia, Asia-Pacific, Europe, North America and Middle-East, and led the life sciences pricing training of the European Pricing Platform from 2011 to 2014.

Raf has university teaching positions on the Master of Science in Pharmaceutical Medicine course of the University of Duisburg-Essen in Germany, and at Grenoble Ecole de Management, a leading French graduate business school, where he teaches the market access module on the Advanced Master’s in Biotechnology & Pharmaceutical Management programme.

Carolyn Steeds
BSc (Hons), PGCert Health Economics

Director – Value Communication

Carolyn has over 30 years’ experience in the healthcare industry, comprising 15 years with Allergan (now AbbVie) in their global HEOR group, 14 years in market access consultancy and 3 years working for a diagnostic company (Bruker Renshaw). With 25 years’ experience in HEOR and market access she has developed key value messages, value communication tools, HTA submissions and economic models for many most of the top global companies over the years.

In her career, Carolyn has worked on pharma product launches for products such as BOTOX and Lumigan while in industry, and in consulting has managed numerous projects working with large global pharmaceutical companies to smaller diagnostic manufacturers, delivering high quality value communication deliverables to support global market access across a wide range of therapy areas including; oncology, infectious diseases, neurology, ophthalmology, medical devices (insulin pumps, gastric bands), in-vitro Diagnostics (biomarker testing for cancer, molecular assays for infection), nutrition and immunology.

Carolyn has an honours degree in Biology from Strathclyde University and a postgraduate certificate in Health Economics from Aberdeen University.

Patricia Buchholz

RPharm, PhD, Dipl. Health Economics, Dipl. Public Health

Associate Director

Patricia has 30 years of experience in healthcare industry, comprising 18 years in pharmaceutical industry, and 12 years in consultancy as well as working as a GCP inspector for a regional health authority in southern Germany.

She has spent over 20 years working in HEOR, P&R and Market Access gaining considerable experience in developing value dossiers and key value messages, market access strategies, value communication strategies, health economic data to support pricing and reimbursement, and outcomes research studies.

Patricia has focused on ophthalmology products (medicinal products, medical devices/IVDs), an area she also covered as medical writer and sales force trainer.

Additionally, Patricia has managed projects working with global pharmaceutical companies and diagnostic manufacturers delivering high quality deliverables across different therapy areas such as oncology and dermatology.

Patricia has a pharmacy degree and PhD from University of Heidelberg (Germany). She has a postgraduate HE diploma from Stockholm School of Economics (Sweden) and a diploma as “Specialist in Public Health”.

She is author of about 30 published articles, mainly in ophthalmology.

Patricia is proficient in German and English and has a good understanding of Spanish and French.

Rachana Patel
MSc, PhD

Data Scientist

Rachana Patel is a Data Scientist at Valid Insight.

Rachana integrates scientific thinking with Machine Learning (ML) and Artificial Intelligence (AI) technologies such as Natural Language Processing (NLP) and Bio-Inspired Computation (BIC) to solve real-world problems.

Before joining, Valid Insight, Rachana worked as a Data Scientist in STMicroelectronics and the ISARIC4C consortium at Edinburgh University after finishing the MSc programme in Data Science from Heriot-Watt University.

Before becoming a Data Scientist, Rachana worked as a Translational Scientist in oncology at the Beatson Institute, Glasgow, after completing a PhD in Biochemistry.

Based on the previous experience, Rachana has a unique combination of skills and expertise in scientific thinking for problem-solving, health care, health technologies, data technologies and computer programming.

Rachana is proficient in Python, R, Java, JavaScript and C# programming languages. In spoken languages, Rachana is proficient in English and various Indian languages (Hindi, Marathi and Gujarati).

For detailed information, please visit:

https://www.researchgate.net/profile/Rachana-Patel-8

Stephen Hall
BSc, MRes, PhD

Consultant

Stephen is a Consultant at Valid Insight. He began his career working as a postdoctoral researcher in Neuroscience, and worked for 2 years at Newcastle University, before working for 7 years as a Wellcome trust researcher at the University of York. Stephen’s work examined the underlying disease pathologies in a wide range of neurological conditions, including epilepsy, Alzheimer’s disease, autism, schizophrenia and encephalopathies. He has published 8 research articles in high impact journals, has presented at numerous conferences and won several awards for his research.

More recently, Stephen worked as the Knowledge Exchange Associate at the NIHR Innovation Observatory, the UK’s national horizon scanning centre. Here he prepared documentation for health technology submissions to NICE, which initiate the technology appraisal process in the UK. He has also worked closely with the NICE topic selection group to communicate the in-depth details underpinning health technology assessments in the UK. This has involved leading online webinars and delivering presentations at a wide range of international conferences.

Stephen has a BSc in Pharmacology from Sunderland University, a MRes in Medical and Molecular Biosciences from Newcastle University and a PhD in Neuropharmacology from Newcastle University.

Pedro Borga
MPharm

Senior Consultant

Pedro is a Senior Consultant at Valid Insight. As part of his pharmacy training, Pedro has worked in a diverse selection of roles across translational research, community pharmacy, hospital pharmacy, distribution and sales, obtaining a holistic view of pharmaceutical supply chain.

He began his consulting career at IMS Health, providing commercial effectiveness solutions to pharmaceutical affiliates in Portugal. He then worked at Lifescience Dynamics and Amaris Consulting, leading global competitive intelligence, market research, market access and pricing projects. Pedro also held a secondment at Autolus as Insights and Analytics Manager.

His market access experience spans commercial strategy, pricing and positioning research, TPP and value message testing, literature review, epidemiology and market sizing, competitive assessment and tracking, interviewing and adboard moderation.

Pedro regularly presents at international conferences regarding rare disease and cell & gene therapy access challenges. He holds a Master of Pharmacy (MPharm) from the University of Lisbon and a postgraduate degree in Economic Evaluation of Medicines from the Lisbon School of Economics and Management.

He is proficient in English and Portuguese, with good understanding of Spanish and French.

Francesca Torelli
MSc, MPhil

Consultant

Francesca Torelli is a consultant at Valid Insight.

Joining in 2020, Francesca has gained experience in value demonstration and market access strategy in a range of chronic diseases at Medtronic, working directly with stakeholders to understand their needs and developing targeted value propositions and communication materials. In addition, Francesca has been involved in evidence generation, collecting real world data and developing economic evidence (such as budget impact and cost-effectiveness analyses).

Francesca also worked as a Research Assistant in Health Economics at the University of Leeds and as a trainee in Global Market Access at Chiesi.

Francesca has presented her work on economic evaluation and PROs at several international conferences. She has an MSc in Economics and Economic Policy from the University of Bologna and a MPhil in Health economics and Management from the University of Oslo.

Paula Martin
DVM, PhD, DACVIM (Neurology)

Senior Consultant

Paula is a Senior Consultant at Valid Insight.

Paula holds a Degree in Veterinary Medicine and a PhD in Comparative and Veterinary Medicine. She is also a Diplomate of the American College of Veterinary Internal Medicine in the specialty of Neurology. Paula worked for 10 years as a companion animal veterinarian, specialising in neurology and neurosurgery. During her veterinary career she was also involved in research and teaching. During this time, she presented her research at various veterinary meetings, published multiple papers in peer-reviewed veterinary and human medicine journals and acted as reviewer for several veterinary journals.

In 2016 she switched careers and became a Senior Medical Writer. She has worked at two award-winning, global Medical Communication and Advertising agencies and as a freelance Senior Medical Writer. Paula has been the Lead Medical Writer for a range of accounts at a national and global level for a variety of pharmaceutical drugs covering multiple therapy areas, including Dermatology, Rheumatology, Neurology, Vaccines, Respiratory, Rare Diseases or Veterinary Medicine, among others. Her work has covered Medical Advertising, Medical Education and publications. She has vast experience developing key value messages from scientific literature to produce story flows which are tailored to different audiences and convey messages effectively.

Paula is a native Spanish speaker and is proficient in English.

Rita Conceição
MPharm

Consultant

Rita Conceição is a Consultant at Valid Insight. Prior to joining Valid Insight, Rita worked at GlaxoSmithKline in the PH Market Access and External Affairs department. Her role enabled her to be involved in a range of projects including pricing and reimbursement submissions, market dynamics activities, global value dossiers and stakeholder reports and communications.

Rita holds a Master of Pharmacy (MPharm) from the University of Lisbon, with complementary courses in HTA and Pharmacoeconomics, and her Master thesis research project took place in Italy, at the University of Pisa.

As part of her pharmaceutical sciences training, Rita had multiple experiences across community pharmacy, immunology and pharmacology research, healthcare IT consulting and pharmaceutical industry, providing her with a broad exposure to the pharmaceutical environment.

Rita is proficient in Portuguese and English and has a good understanding of Spanish and Italian.

Roberta Longo
MSc, PhD

Consultant

Roberta Longo is a consultant at Valid Insight.

Roberta is a health economist with over 10-year academic experience in economic evaluation and modelling of health care interventions, treatments and diagnostic tests . She holds an MSc in Health Economics from the University of York and a PhD in Economics from the University of Rome “La Sapienza” (Italy).

Prior to joining Value Insight, she was first Research Fellow and then Lecturer in the Academic Unit of Health Economics at the University of Leeds, where she still holds a Visiting Lecturer title.

During her 12-year academic career, she secured grant income as co-applicant on several successfully funded NIHR projects; conducted cost-effectiveness analyses on landmark trials in heart failure, osteoarthritis, diabetic foot ulcers and IBS; co-authored multiple peer-reviewed publications and presented results of her research at international conferences.

For many years she has provided health economics consult on research grant applications within the NIHR Research Design Service and the NIHR Leeds Diagnostics Evidence Co-operative. Roberta still acts as reviewer for several health economics journals as well as for the NIHR HTA funding programme.

Roberta is an Italian native speaker with full English proficiency.

Alba San Segundo
MPharm

Associate Consultant

Alba has several years of experience as a community pharmacist, where she was accountable for business development, commercial operations and marketing campaigns.

Before joining Valid Insight, Alba was part of the Market Access Department at Merck Sharp & Dohme, gaining experience in stakeholder targeting & segmentation, environmental analysis, development of value propositions for key audiences and creation of new product content and materials. She dealt with several therapeutic areas including immunology, rheumatology, infectious diseases and oncology.

She is a native Spanish speaker and fluent in English.

Maria Ana Almeida
MPharm

Associate Consultant

Maria is an Associate Consultant at Valid Insight. She holds a Master of Pharmacy (MPharm) from University of Lisbon with a final thesis on the use of Big data across the medicine´s lifecycle.

As part of her graduation Maria had a lot of different experiences dealing with areas such as clinical trials, immunology, pharmacology, information technologies and she did a supplementary course in Marketing for pharmacists. She has done some laboratory work and internships in community pharmacy in Portugal and in the UK.

Prior to joining Valid Insight, Maria worked in numerous digital brand launch projects, as a speaker on Big data and Data Sciences.

These experiences have equipped her with a broad scientific knowledge and key communication, project management, analytical, problem solving and team working skills.

Maria is a native Portuguese speaker and fluent in English.

Federico Ghinelli
MSc

Associate Consultant

Federico is an Associate Consultant at Valid Insight. He holds an MSc in Health Economics, Management and Policy from the University of Bologna with a final thesis on the development of a cost-effectiveness analysis of prosthetic implant combinations in total hip replacement in Italy, through a collaboration with the Region Emilia-Romagna’s health service.

Prior to joining Valid Insight, Federico was part of the Healthcare and Public Sector Consulting line of service at KPMG Italy, where he worked on projects dedicated to supporting the development and deployment of ICT solutions for healthcare at a regional and local level in the country.

He is a native Italian speaker and fluent in English.

Ayesha Qureshi
BSc

Associate Consultant

Ayesha is an Associate Consultant at Valid Insight. She holds a BSc in Medical Biochemistry from the University of Manchester and a Masters in Pharmaceutical Formulation and Entrepreneurship from University College London (UCL).

Through her studies, Ayesha has gained extensive knowledge in market access and business development particular to pharmaceuticals and life sciences with regards to business viability, technological feasibility, and regulatory constraints. Her knowledge ranges from developing market landscapes and competitor landscapes to building stake-holder maps. Her studies have further equipped Ayesha with experiences ranging from interviewing founders, analysing their company’s financial journey, and building a valuable network overall.

Darlene Lucion
MSc

Associate Consultant

Darlene Lucion is an Associate Consultant at Valid Insight. She holds an MSc in Bioscience Entrepreneurship from University College London and a BSc in Biology from Royal Holloway University of London.

She has experience working for healthtech start-ups such as Solvemed Group and Phenopolis, overseeing research, competitive landscapes, grant proposals and compliance. She also worked as a digital health analyst for PATH where she built a framework to integrate artificial intelligence and machine learning health initiatives across low-income countries, specifically LATAM.

Prior to joining Valid Insight, Darlene worked as a Research Executive for a market research firm where she predominantly ensured medical devices conformed to the EU medical device regulations by designing and conducting post-market clinical follow up surveys. By leading various projects using several research techniques, she was able to work in several disease areas and understand the perspectives of various stakeholders in the healthcare industry.

Anna Świder
MPharm

Associate Consultant

Anna is an Associate Consultant at Valid Insight. She holds a Master of Pharmacy (MPharm) from the Jagiellonian University in Cracow, as well as the postgraduate diploma in Interdisciplinary Studies in Pharmaceutical Management from the Warsaw University of Technology Business School.

Anna began her career working as a Junior Analyst at HTA Consulting, where she was involved in conducting the systematic literature reviews for a global pharmaceutical company.

Prior to joining Valid Insight, Anna worked as an Analyst at Creativ-Ceutical, the global market access & HEOR consulting company. She gained experience in a range of projects including competitive landscape analysis, environmental assessment, development of the global value dossiers and the post-approval AMCP dossier for FDA submission. She has an experience in working in the disease areas such as dermatology, oncology, with the focus on the psychiatry and neurology.

Anna is a native Polish speaker and fluent in English.

Annie Smith
MSc

Associate Consultant

Annie is an Associate Consultant at Valid Insight.

She holds a Master by research in molecular neuroscience from Swansea University. Her work examined the underlying disease pathology of Parkinson’s related dementia, and she has a strong scientific background in neuroscience and immunology. As part of her studies, she has presented at international conferences including Society for Neuroscience and won awards for her research such as the KM Scott Prize for best academic talk.

She has extensive experience in project management, data handling, scientific communication, and analytics, and has taken part in multi-discipline collaborative projects which included team leadership roles. Annie has partaken in several scientific-communication community outreach projects and has designed and run an undergraduate development module at the University of York.

She holds a first-class honours degree in Biochemistry from Swansea University.

Evangelia Siamopoulou
BSc, MSc

Associate Consultant

Evangelia is an Associate Consultant at Valid Insight. She holds a BSc in Chemistry from the University of Athens and an MSc in Drug Discovery and Pharma Management from University College London (UCL).

Prior to joining Valid Insight, Evangelia had an internship as a Business development intern within a pharma consulting company, gaining experience into the fields of business developing plan, data analysis and project management.

Through her studies, she has gained extensive knowledge in market access and business development particular in pharmaceuticals and life sciences. Her knowledge ranges from primary stages of development from the laboratory, until the final market access.

Evangelia is a native Greek speaker, fluent in English and has a good understanding of French.

Sue Caleo-Naeyaert
Bpharm. Grad.Dip.Sc(Pharm). MCom

Senior Advisor

Sue Caleo-Naeyaert is a senior international executive in the areas of Pricing, Market Access, Health Economics, Government Affairs and Policy who has lived and worked in Europe, Switzerland, Asia, and the United States with experience spanning 26 years. Sue began her career as a community pharmacist, but soon decided to further her studies and work experience at the University of Sydney specialising in the area of health economics.

In 1998, Sue was awarded a research fellowship by the EORTC (European Organisation for Research and Treatment in Cancer) in the health economics of cancer, based in Brussels, Belgium. This was followed by her move into the pharmaceutical industry, where she worked in Australia for Janssen, and then at a Global level with J&J based back in Belgium for 5 years. In 2009, Sue moved with Merck Serono to Singapore to set up their Regional Pricing and Market Access department for Asia-Pacific. After 3 and 1/2 years, Merck asked her to move to Switzerland as Global Head Pricing and Market Access for their Biosimilars Unit. Here Sue expanded her role to include the Government Affairs and Policy areas, with a 14-month secondment to Washington DC. During 2017, Fresenius Kabi bought the Biosimilars Unit of Merck KGaA and Sue continued in her role as Global Head of Government affairs, Policy and Pharmacoeconomics.

Sue is now a Senior Advisor for Valid Insight whilst being a regular guest speaker at conferences across the globe, and having numerous peer-reviewed publications. She has a Bachelor of Pharmacy, a Graduate Diploma of Pharmacy (with a specialisation in health economics) and a Master of Commerce with an Advanced Specialisation in Business Economics and Statistics.

Alia Karaouni
BSc, MSc, PhD

Senior Advisor

Alia Karaouni is Senior Advisor at Valid Insight. She is an experienced strategy consultant and foresight expert. Alia has a proven track record in decision support for senior pricing and market access management in the pharmaceutical industry. Her in-depth knowledge of biotech and pharma stems from 15 years of consultancy work, as well as work in the industry, on issues related to pricing strategy, market access, portfolio analysis, cost-benefit assessment, commercial planning and valuation, among others.

Alia has over 20 years’ experience helping clients tackle complex management decision-making in highly-uncertain, rapidly-changing environments, through issue framing, discussion facilitation and simulation-tool building. Alia was head of market access for three years ad interim at Onxeo, a Paris-based small biotech company with several orphan oncology drugs in development. Prior to this, she worked for the World Economic Forum in Geneva, as deputy head of scenario planning. Here she directed several year-long scenario projects exploring the future of industries and regions, with the outcomes made public at the annual Davos meeting. She has also worked as a management consultant in Brussels for IBM Business Consulting Services and PricewaterhouseCoopers, before setting up her own independent company, using her expertise in the field of systems thinking and business modelling to support business strategy and decision-making

Alia holds a PhD in Economics from MIT, a Master’s degree in Econometrics and a Bachelor’s degree in Economics from Université de Montréal.

Carole Alison Chrvala
MA, PhD

Senior Advisor

Carole Chrvala is Senior Advisor at Valid Insight. She has nearly 30 years’ experience as an epidemiologist and HEOR researcher. Her work spans collaborations with government health agencies, payers, academic institutions, pharmaceutical and medical device companies, medical education and communication organisations, and healthcare professional societies located in the US, UK, EU, and Israel. Carole is highly experienced in epidemiologic consulting, biostatistical support, strategic competitive analysis, medical intelligence, medical writing and publication planning services in diverse therapeutic areas including oncology, cardiovascular disease, diabetes mellitus, infectious diseases, musculoskeletal disorders, neurologic disorders, pain, psychiatric disorders, rare diseases, respiratory disorders, rheumatologic disorders, and women’s health.

Carole has developed and validated risk prediction models for various chronic and infectious diseases, analysed health care resource utilisation and economic burden, determined projections for the global epidemiologic burden of diverse health conditions, developed prospective and retrospective research studies to examine the impact of clinical interventions and developed statistical analysis plans for retrospective and prospective case-control studies and randomised clinical trials.

Carole was director of Cancer Prevention and Control for the Colorado Department of Public Health and Environment (CDPHE), before setting up her own independent company. She joined the US Food and Drug Administration as a Senior Scientist and later joined the National Academies of Science as a Senior Program Officer. She has written and presented on epidemiology, health economics and outcomes research, and diverse health topics to more than 75 professional audiences and organisations.

LEARN MORE ABOUT VALID INSIGHT

Download our brochure now to learn more about us and how we can support your market access work.

Download Now

GET IN TOUCH

Please use the contact form if you have any questions about our services.

UK OFFICE ADDRESS

Ropewalks

Newton Street

Macclesfield

Cheshire

SK11 6QJ

discover@validinsight.com

+44 (0) 20 3750 9833

Who We Are

OUR MARKET ACCESS CONSULTANCY TEAM

Janice Haigh

JAMES WRIGHT

FRANK COUSINS

RAF DE WILDE

CAROLYN STEEDS

PATRICIA BUCHHOLZ

RACHANA PATEL

STEPHEN HALL

PEDRO BORGA

Francesca Torelli

Paula Martin

RITA CONCEIÇÃO

ROBERTA LONGO

ALBA SAN SEGUNDO

MARIA ANA ALMEIDA

FEDERICO GHINELLI

AYESHA QURESHI

DARLENE LUCION

ANNA ŚWIDER

ANNIE SMITH

EVANGELIA SIAMOPOULOU

SUE CALEO-NAEYAERT

ALIA KAROUNI

CAROLE CHRVALA

LEARN MORE ABOUT VALID INSIGHT

GET IN TOUCH

UK OFFICE ADDRESS